drug
as of 2026-07-01Intranasal Insulin
Intranasal insulinintranasal Insulin
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central Institute of Mental Health, Mannheim
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
4
Dopamine and Insulin in Psychosis
NCT07252752—Not Yet Recruiting
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
NCT05748990—Recruiting
Evaluation Study of New Compounds With Potential Use in Schizophrenia
NCT00916201Phase 1Withdrawn
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
NCT03943537Phase 2Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
KOL
F. Markus Leweke, MD
personKOL score 9
Virginie-Anne Chouinard, M.D.
personKOL score —